Nemonapride (エミレース, Emilace (
JP)) is an
atypical antipsychotic
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), are a group of antipsychotic drugs (antipsychotic drugs in general are also known as major tranquilizers and ne ...
approved in
Japan for the treatment of
schizophrenia
Schizophrenia is a mental disorder characterized by continuous or relapsing episodes of psychosis. Major symptoms include hallucinations (typically hearing voices), delusions, and disorganized thinking. Other symptoms include social wit ...
. It was launched by
Yamanouchi in May 1991.
Nemonapride acts as a
D2 and
D3 receptor antagonist, and is also a potent
5-HT1A receptor agonist.
It has affinity for
sigma receptors.
See also
*
Benzamide
Benzamide is a organic compound with the chemical formula of C6H5C(O)NH2. It is the simplest amide derivative of benzoic acid
Benzoic acid is a white (or colorless) solid organic compound with the formula , whose structure consists of a benz ...
References
Atypical antipsychotics
Benzamides
Chloroarenes
Phenol ethers
Pyrrolidines
{{nervous-system-drug-stub